Cabecera

Contenido extra

 
 

Contenido extra

 
 

Contenido extra

 
 

Contenido extra

 
 

CONTENIDO

Notices

We can tell the tale

“We can tell the tale” is the slogan of Fundación Grupo IMO that can be seen in Madrid´s Metro in support of the fight against cancer

NAZCA acquires a majority stake in the spanish GRUPO IMO

The transaction values Grupo IMO in ¤50M.  Upon deal completion, NAZCA will retain a majority shareholding in the company.

Murcia: a reference in the field of International Training for Radiation Therapy Specialists

In a closing speech marking the second edition of the Masters and the opening ceremony of the third edition, Mr José Sanblás, chairman of Grupo IMO and Grupo IMO Foundation advocated for the application of the new technologies, such as real-time image-

Three out of four relatives of breast cancer patients would have welcomed stronger emotional support.

Grupo IMO’s Psycho-Oncology unit ran a pilot study proving that 9 out of 10 breast cancer patients deem that enough emotional and instrumental support was provided by their relatives, whereas 8 out of 10 claim that they received enough emotional

Together, we win.

Together, we win.

17/10/2011

Grupo IMO Foundation has launched a campaign aimed at strengthening social and family bonds with cancer patients and survivors. For most relatives this is a deep emotional shock similar to what patients feel after being diagnosed.

Acknowledgement of Business and Healthcare excellence in Grupo IMO.

As authorized member of the Excellent Private Health Care Program, Grupo IMO - Madrid's Institute of Oncology has been awarded both prizes for its continued business and healthcare excellence. Both prizes were awarded by Áliad, a leading expert in trai

Theory-practice course on real-time Image-guided Robotic Radiation Therapy (Cyberknife)

Team of Robotic Radiation Therapy Surgery with Cyberknife.

Agreement between Grupo IMO Foundation and the Chilean Foundation Arturo López Pérez.

Both institutions have entered into a joint cooperation agreement with teaching, research and assistance purposes in order to strengthen the fight against cancer. 

Only 1 out of 100 women with breast cancer experiences a relapse after IORT.

Official opening of the International IORT Course organized by Grupo IMO Foundation 

With the new Cyberknife it is possible to provide efficient treatment against prostate cancer in just five days.

Robotic Radiation Therapy with Cyberknife shortens treatment times and avoids side effects such as urinary incontinence and sexual dysfunction.

Grupo IMO incorporates a new protocol against breast cancer that allows efficient treatment only in five days.

Radiation therapy with TOMOTHERAPY is more efficient, less toxic and improves breast cancer patients’ quality of life. 

FirstPrevious
 

Pie